Our vision is to fundamentally transform prenatal diagnostics by making cell-free non-invasive prenatal testing (cfNIPT), chorionic villus sampling (CVS) and amniocentesis (Amnio) obsolete.

Our vision is to fundamentally transform prenatal diagnostics by making cell-free non-invasive prenatal testing (cfNIPT), chorionic villus sampling (CVS) and amniocentesis (Amnio) obsolete.

If you are pregnant

ARCEDI’s prenatal tests can give you peace of mind concerning your future child. Learn more about EVITA TEST COMPLETE and EVITA TEST GENDER at evitatest.com

TECHNOLOGY

ARCEDI’s unique technology isolates fetal cells from maternal blood and uses them for genetic analysis

PRODUCT

With ‘EVITA TEST COMPLETE’ ARCEDI is the first company to provide genome-wide analysis of the fetus using circulating fetal cells

PATENTS

ARCEDI’s strong IP portfolio covers four patents and provides global protection through 2031

Latest news

Presentation at CoGEN-2021

Line Dahl Jeppesen presents her PhD project at CoGEN-2021 meeting Line Dahl Jeppesen who is doing her PhD at ARCEDI Biotech presented a talk at the 8th CoGEN meeting

Read More »

Newsletter

Subscribe to our newsletter to get the latest updates on products and new scientific publications on ARCEDI technology.